[1]蒋伟,奚俊杰,王群,等.全胸腔镜肺癌根治术淋巴结清扫的探讨[J].中国微创外科杂志,2012,12(11):969-975.
 Jiang Wei,Xi Junjie,Wang Qun,et al.Complete Videoassisted Thoracoscopic Surgery versus Open Mediastinal Lymphadenectomy for Nonsmall Cell Lung Cancer[J].Chinese Journal of Minimally Invasive Surgery,2012,12(11):969-975.
点击复制

全胸腔镜肺癌根治术淋巴结清扫的探讨()
分享到:

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
12
期数:
2012年11期
页码:
969-975
栏目:
出版日期:
2012-11-20

文章信息/Info

Title:
Complete Videoassisted Thoracoscopic Surgery versus Open Mediastinal Lymphadenectomy for Nonsmall Cell Lung Cancer
作者:
蒋伟奚俊杰王群汪灏葛棣谭黎杰范虹徐松涛徐正浪
复旦大学附属中山医院胸外科,上海200032
Author(s):
Jiang Wei Xi Junjie Wang Qun et al
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
关键词:
胸腔镜非小细胞肺癌肺叶切除术淋巴结清扫
Keywords:
Videoassisted thoracoscopic surgeryNonsmall cell lung cancerLobectomyLymph node dissection
分类号:
R734.2
文献标志码:
A
摘要:
目的 探讨全胸腔镜下肺叶切除治疗临床Ⅰ期非小细胞肺癌淋巴结清扫的安全性和可行性。方法 2006年1月~2008年12月,160例临床Ⅰ期非小细胞肺癌接受全腔镜下肺叶切除术、纵隔淋巴结清扫,采用不撑开肋骨三孔法,并与同期247例接受常规开放手术的Ⅰ期非小细胞肺癌进行比较。结果 胸腔镜组淋巴结清扫组数(2.4±1.5)组与开胸组(2.6±1.6)组无显著差异(t=1.262,P=0.208),胸腔镜组清扫淋巴结(9.8±6.2)枚,与开胸组(9.9±5.9)枚无统计学差异(t=-0.160,P=0.873)。开胸组并发症发生率11.7%(29/247)和围手术期死亡率2.8%(7/247)与胸腔镜组并发症发生率9.4%(15/160)和围手术期死亡率0.6%(1/160)无显著差异(χ2=0.564,P=0.453; χ2=1.446,P=0.229)。胸腔镜组生存情况优于开胸组(χ2=5.373,P=0.020)。结论 全胸腔镜肺叶切除术治疗临床Ⅰ期非小细胞肺癌在技术上是安全可行的,其淋巴结清扫可达到开放手术的范围,远期疗效不亚于开放手术。
Abstract:
ObjectiveTo evaluate the safety and feasibility of videoassisted thoracoscopic surgery (VATS) for lobectomy in patients with stage Ⅰ nonsmall cell lung cancer. MethodsWe retrospectively analyzed the clinical data of 160 patients with stage Ⅰ nonsmall cell lung cancer, who underwent VATS for lobectomy and mediastinal lymphadenectomy in our hospital, from January 2006 to December 2008. Another 247 patients with stage Ⅰ nonsmall cell lung cancer, who underwent open surgery during the same period, were set as a control group.ResultsNo significant difference existed between the VATS and control groups in the numbers of removed lymph node groups and lymph nodes [2.4±1.5 and 9.8±6.2 vs. 2.6±1.6 and 9.9±5.9; t=1262, P=0208 and t=-0.160, P=0.873, respectively], or the rates of complications and perioperative mortality [9.4% (15/160) and 06% (1/160) vs. 11.7% (29/247) and 2.8% (7/247), χ2=0.564, P=0.453 and χ2=1.446, P=0.229, respectively]. However, the VATS group had a higher survival rate than the control group (χ2=5.373, P=0.020). ConclusionsVATS is safe and feasible for lobectomy and mediastinal lymphadenectomy in patients with stage Ⅰ nonsmall cell lung cancer, and is effective as open surgery in the scope of lymphadenectomy. Its longterm efficacy is as good as open surgery.

参考文献/References:

[1]杨帆,李晓,王俊,等.连续300例全胸腔镜肺叶切除术及中期随访分析.中国胸心血管外科临床杂志,2011,18(2):95-98.
[2]张轶,姜格宁,朱余明,等.电视胸腔镜肺叶切除术临床疗效分析.第二军医大学学报,2010,31(7):770-774.
[3]谭黎杰,王群,徐正浪,等.肺叶切除几种微创术式比较.中华胸心血管外科杂志,2005,21(2):78-79.
[4]McKenna RJ Jr, Houck W, Fuller CB. Videoassisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg,2006,81(2):421-426.
[5]Kim K, Kim HK, Park JS, et al. Videoassisted thoracic surgery lobectomy: single institutional experience with 704 cases. Ann Thorac Surg,2010,89(6):2118-2122.
[6]Ichinose J, Kohno T, Fujimori S, et al. Locoregional control of thoracoscopic lobectomy with selective lymphadenectomy for lung cancer. Ann Thorac Surg,2010,90(1):235-239.
[7]Martini N. Mediastinal lymph node dissection for lung cancer. The memorial experience. Chest Surg Clin N Am,1995,5(2):189-203.
[8]杨学宁,林欢,吴一龙.临床Ⅰ期非小细胞肺癌的选择性淋巴结清扫术.癌症进展,2010,8(6):549-553.
[9]Watanabe SI, Asamura H. Lymph node dissection for lung cancer: significance, strategy, and technique. J Thorac Oncol,2009,4(5):652-627.
[10]Park BJ. Is surgical morbidity decreased with minimally invasive lobectomy? Cancer J,2011,17(1):18-22.
[11]Yan TD, Black D, Bannon PG, et al. Systematic review and metaanalysis of randomized and nonrandomized trials on safety and efficacy of videoassisted thoracic surgery lobectomy for earlystage nonsmallcell lung cancer. J Clin Oncol,2009,27(15):2553-2562.
[12蒋伟,奚俊杰,汪灏,等.全胸腔镜肺叶切除术治疗临床早期非小细胞肺癌的疗效评价.中国胸心血管外科临床杂志,2012,19(2):120-124.
[13]Whitson BA, Groth SS, Duval SJ, et al. Surgery for earlystage nonsmall cell lung cancer: a systematic review of the videoassisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg,2008,86(6):2008-2018.
[14]Ludwig MS, Goodman M, Miller DL, et al. Postoperative survival and the number of lymph nodes sampled during resection of nodenegative nonsmall cell lung cancer. Chest,2005,128(3):1545-1550.
[15]RamiPorta R, Wittekind C, Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer,2005,49(1):25-33.
[16]罗宜人,王耀鹏,王明钊,等.临床Ⅰ期非小细胞肺癌电视胸腔镜肺叶切除术中淋巴结清扫的对照研究.中国微创外科杂志,2011,11(1):73-75.
[17]Scott WJ, Allen MS, Darling G, et al. Videoassisted thoracic surgery versus open lobectomy for lung cancer: A secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg,2010,139(4):976-983.

备注/Memo

备注/Memo:
王群通讯作者,Email:wang.qun@zshospital.sh.cn
更新日期/Last Update: 2013-03-27